NFKB1 and cancer: Our data showed that EriB covalently modifies cysteine 62 of p50 through the α,β-unsaturated ketones and EriB induces cancer cell apoptosis through interfering with the binding between NF-κB and the response elements by directly targeting the cysteine 62 of p50.